carbapenems has been researched along with Primary Peritonitis in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 8 (25.81) | 2.80 |
| Authors | Studies |
|---|---|
| Amico, G; Conaldi, PG; Douradinha, B; Gruttadauria, S; Iannolo, G; Mularoni, A; Pampalone, M; Pietrosi, G; Vitale, G | 1 |
| Boussekey, N; Caulier, T; Delannoy, PY; Devos, P; Georges, H; Jean-Michel, V; Krings, A; Leroy, O; Thellier, D | 1 |
| ELshamy, RM; Oda, MS; Ramadan, RA; Saeed, MA | 1 |
| Arora, V; Jindal, A; Maiwall, R; Prakash, V; Sarin, SK | 1 |
| Heckler, M; Kleeff, J; Michalski, CW; Rebelo, A; Schlicht, L | 1 |
| Barquist, L; Blaskovich, MAT; Boinett, CJ; Butler, MS; Cain, AK; Cooper, MA; Edwards, IA; Elliott, AG; Huang, JX; Lociuro, S; Lundberg, CV; Mobli, M; Neve, S; Porter, KM; Steen, J; Strandh, M; Zuegg, J | 1 |
| Cho, EJ; Choi, DH; Chung, SW; Jang, HJ; Jung, YJ; Kang, SH; Kim, MA; Kim, MY; Kim, SW; Kim, YJ; Lee, CH; Lee, HA; Lee, JH; Lee, JS; Lee, M; Lee, YB; Oh, H; Park, J; Park, JM; Seo, YS; Song, DS; Song, J; Yang, JM; Yoon, JH; Yoon, JS; Yu, SJ | 1 |
| Chau, F; Cheminet, G; de Lastours, V; Fantin, B; Massias, L; Nordmann, P; Peoc'h, K; Poirel, L | 1 |
| Aurilio, C; Borgia, G; Fiore, M; Gentile, I; Leone, S; Maraolo, AE; Pace, MC; Passavanti, MB; Sansone, P | 1 |
| Gao, P; Ho, PL; Kao, RY; Lai, TP; Li, H; Ma, G; Sun, H; Wang, R; Woo, PC; Zhang, H | 1 |
| Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E | 1 |
| Arora, R; Chawla, R; Goel, R; Narula, A; Sharma, RK; Thakur, P | 1 |
| Cheng, X; Ge, M; Ruan, L; Wan, G; Yang, T; Yin, Y | 1 |
| Chen, H; Chen, YG; Li, LJ; Li, YM; Praseedom, RK; Xie, HY; Zhang, Y; Zheng, SS; Zhou, L | 1 |
| Depestel, DD; Paterson, DL | 1 |
| Guery, BP | 1 |
| Lumb, J | 1 |
| Dahyot, S; Mammeri, H | 1 |
| Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC | 1 |
| Angeli, P; Gatta, A; Piano, S; Romano, A; Rosi, S | 1 |
| Bi, S; Fan, W; Huang, Y; Ji, Z; Li, L; Wiradharma, N; Xu, K; Yang, YY | 1 |
| Shinagawa, N; Takeyama, H; Taniguchi, M | 1 |
| Ohnishi, H; Ohta, M; Oshiro, S; Tsuchimochi, H | 1 |
| Briskin, BS; Khachatrian, NN; Khmelevskiĭ, SV; Poliakov, IA; Savchenko, ZI | 1 |
| Ibi, R; Itou, M; Iwasaki, S; Kawaguchi, T; Kumashiro, R; Kuwahara, R; Matsuda, T; Nagao, Y; Oriishi, T; Otsuka, M; Saruwatari, Y; Sata, M; Shimada, M; Shiraishi, S; Tanaka, S; Taniguchi, E | 1 |
| Kioumis, IP; Kuti, JL; Nicolau, DP | 1 |
| Weigelt, JA | 1 |
| Dibirov, MD; Karsot'ian, GS; Khachatrian, NN; Khmelevskiĭ, SV; Poliakov, IA | 1 |
| Mikamo, H; Shinagawa, N; Takesue, Y; Takeyama, H; Tanaka, K; Taniguchi, M; Watanabe, K; Yokoyama, T | 1 |
| Wilson, SE | 1 |
| Bradley, JS; Garau, J; Lode, H; Quinn, JP; Rolston, KV; Wilson, SE | 1 |
9 review(s) available for carbapenems and Primary Peritonitis
| Article | Year |
|---|---|
Carbapenem Antibiotics Versus Other Antibiotics for Complicated Intra-abdominal Infections: a Systematic Review and Patient-Level Meta-analysis of Randomized Controlled Trials (PROSPERO CRD42018108854).
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Peritonitis; Randomized Controlled Trials as Topic | 2023 |
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Liver Cirrhosis; Methicillin; Methicillin-Resistant Staphylococcus aureus; Peritonitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Treatment Outcome; Vancomycin-Resistant Enterococci | 2017 |
Basis for selecting optimum antibiotic regimens for secondary peritonitis.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Peritonitis; Practice Guidelines as Topic; Risk Factors; Tigecycline | 2016 |
Doripenem.
Topics: Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Peritonitis; Pneumonia, Bacterial; Seizures; Urinary Tract Infections | 2009 |
[Doripenem: need for a new carbapenem].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections | 2009 |
Intra-abdominal infections: considerations for the use of the carbapenems.
Topics: Carbapenems; Drug Resistance, Bacterial; Humans; Peritonitis | 2007 |
Empiric treatment options in the management of complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Doripenem; Drug Resistance, Bacterial; General Surgery; Humans; Internal Medicine; Minocycline; Peritoneal Cavity; Peritonitis; Risk Factors; Severity of Illness Index; Surgical Wound Infection; Tigecycline | 2007 |
Carbapenems: monotherapy in intra-abdominal sepsis.
Topics: Adult; Bacterial Infections; Carbapenems; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic | 1995 |
Carbapenems in clinical practice: a guide to their use in serious infection.
Topics: Bacterial Infections; Carbapenems; Child; Drug Resistance, Microbial; Fever; Humans; Intensive Care Units; Meningitis, Bacterial; Neutropenia; Peritonitis; Pneumonia | 1999 |
2 trial(s) available for carbapenems and Primary Peritonitis
| Article | Year |
|---|---|
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: A randomized controlled trial.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Liver Cirrhosis; Meropenem; Peritonitis | 2023 |
Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Carbapenems; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycoproteins; Humans; Immunologic Factors; Intestinal Obstruction; Liver Abscess; Male; Middle Aged; Pancreatitis; Peritonitis; Sepsis; Thymalfasin; Thymosin | 2008 |
20 other study(ies) available for carbapenems and Primary Peritonitis
| Article | Year |
|---|---|
Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant
Topics: Amnion; Bacterial Load; beta-Lactam Resistance; Biomarkers; Carbapenems; Complement Activation; Complement System Proteins; Disease Susceptibility; Enterobacter; Enterobacteriaceae Infections; Humans; Immunomodulation; Inflammation Mediators; Macrophages; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Peritoneal Fibrosis; Peritonitis; Phagocytosis; Receptors, Pattern Recognition; Treatment Outcome | 2022 |
Severe secondary peritonitis: impact of inappropriate initial antimicrobial therapy on prognosis and potential carbapenem-sparing.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intensive Care Units; Peritonitis; Prognosis; Retrospective Studies | 2022 |
A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Hospitals, University; Humans; Liver Cirrhosis; Microbial Sensitivity Tests; Peritonitis | 2022 |
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Cell Membrane Permeability; Colistin; Disease Models, Animal; Drug Discovery; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Helminth Proteins; Humans; Male; Mice; Microbial Sensitivity Tests; Peritonitis; Pneumonia; Urinary Tract Infections | 2020 |
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Liver Cirrhosis; Peritonitis; Retrospective Studies | 2021 |
Dimercaptosuccinic acid in combination with carbapenems against isogenic strains of Escherichia coli producing or not producing a metallo-β-lactamase in vitro and in murine peritonitis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Mice; Microbial Sensitivity Tests; Peritonitis; Succimer | 2020 |
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors.
Topics: Animals; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Bismuth; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Dogs; Drug Evaluation, Preclinical; Evolution, Molecular; Female; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Organometallic Compounds; Peritonitis; Zinc | 2018 |
Assessment of aquo-ethanolic extract of Camellia sinensis against Carbapenem Resistant Escherichia coli: In Vivo Trials in a Murine Model.
Topics: Animals; Camellia sinensis; Carbapenems; Chromatography, Liquid; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Ethanol; Humans; Kidney; Male; Mass Spectrometry; Maximum Tolerated Dose; Mice; Peritonitis; Plant Extracts; Rats, Sprague-Dawley; Reference Standards; Water | 2016 |
Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Humans; Male; Metal Nanoparticles; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peritonitis; Rifampin; Silver | 2016 |
Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10-13 April 2010.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Peritonitis | 2010 |
Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Cloning, Molecular; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Peritonitis; Postoperative Complications; Protein Structure, Tertiary | 2012 |
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins | 2012 |
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge.
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Fatty Liver; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis | 2012 |
Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Drug Resistance, Bacterial; Humans; Lethal Dose 50; Lung; Male; Mice; Peritoneum; Peritonitis; Pneumonia; Structure-Activity Relationship | 2012 |
[A questionnaire survey on antimicrobial chemotherapy for acute peritonitis].
Topics: Acute Disease; Anti-Bacterial Agents; Carbapenems; Cefotiam; Clinical Competence; Consensus; Humans; Intestinal Perforation; Perioperative Care; Peritonitis; Surveys and Questionnaires | 2002 |
Intraventricular rupture of Nocardia brain abscess--case report.
Topics: Abdominal Pain; Aged; Brain Abscess; Carbapenems; Cerebral Ventricles; Confusion; Diagnosis, Differential; Drainage; Fatal Outcome; Functional Laterality; Humans; Laparotomy; Lymphoma; Magnetic Resonance Imaging; Male; Meningitis; Neurosurgical Procedures; Nocardia asteroides; Nocardia Infections; Paresis; Parietal Lobe; Peritonitis; Radiography; Rupture, Spontaneous | 2003 |
[Treatment of severe forms of generalized peritonitis].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Gastrointestinal Diseases; Humans; Laparotomy; Middle Aged; Peritonitis; Reoperation; Severity of Illness Index | 2003 |
Branched-chain amino acid supplementation complements conventional treatment for spontaneous bacterial peritonitis.
Topics: Abdominal Pain; Aged; Amino Acids, Branched-Chain; Blood Chemical Analysis; Carbapenems; Dietary Supplements; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Liver Failure; Peritonitis | 2006 |
[The role of carbapenems in combined therapy of patients with common forms of peritonitis].
Topics: Carbapenems; Drug Therapy, Combination; Emergencies; Humans; Length of Stay; Peritonitis; Postoperative Care; Prospective Studies; Retrospective Studies; Risk Factors; Time Factors | 2007 |
[Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestinal Perforation; Male; Middle Aged; Peritonitis | 2007 |